IMAGEN BIOTECH
Imagen Biotech, Inc. is a private, venture-backed biopharmaceutical company focused on identifying and developing therapeutics for blinding diseases with high unmet medical needs, including dry age-related macular degeneration. Since its formation in the summer of 2011 with financing from SV Life Sciences, Novo Ventures and Fidelity Biosciences, Imagen continues to evaluate numerous compounds sourced worldwide to determine their feasibility as drug development candidates. The Company was co-foun... ded by ophthalmologists Matthew Feinsod, MD, former medical officer at FDA and later SVP with Eyetech Pharmaceuticals, and David Guyer, MD, former founder and CEO of Eyetech Pharmaceuticals and current partner with SV Life Sciences. Imagen is funded to develop approximately three compounds through predetermined milestones.
IMAGEN BIOTECH
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-06-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.imagenbiotech.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
Google Apps For Business PHP OpenResty Register.com DNS Network Solutions
Similar Organizations
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Theragene Pharmaceuticals
Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.
Current Employees Featured
Founder
Investors List
F-Prime Capital
F-Prime Capital investment in Series A - Imagen Biotech
Novo Ventures
Novo Ventures investment in Series A - Imagen Biotech
SV Health Investors
SV Health Investors investment in Series A - Imagen Biotech
Official Site Inspections
http://www.imagenbiotech.com
- Host name: 208.91.197.39
- IP address: 208.91.197.39
- Location: British Virgin Islands
- Latitude: 18.5
- Longitude: -64.5
- Timezone: America/Tortola
